好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A vaccine targeting mutant IDH1 induces antitumor immunity
Neuro-oncology
(-)
001
Authors/Disclosures
Michael Platten, MD (University Hospital of Heidelberg)
PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Manuel Alexander Friese, MD Dr. Friese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Friese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Friese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sudo Biosciences. Dr. Friese has received personal compensation in the range of $0-$499 for serving as a Consultant for Kyverna. Dr. Friese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Friese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wings for Life. The institution of Dr. Friese has received research support from Deutsche Forschungsgemeinschaft . Dr. Friese has received research support from Bundesministerium für Bildung und Forschung.
Andreas von Deimling No disclosure on file
Wolfgang Wick The institution of Wolfgang Wick has received research support from Roche. The institution of Wolfgang Wick has received research support from Pfizer. The institution of Wolfgang Wick has received research support from Apogenix.